VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $401,470 | +2.5% | 14,919 | +14.7% | 0.00% | 0.0% |
| Q2 2023 | $391,580 | +1.2% | 13,005 | +8.7% | 0.00% | 0.0% |
| Q1 2023 | $387,068 | +3.1% | 11,965 | -8.6% | 0.00% | 0.0% |
| Q4 2022 | $375,302 | +29.0% | 13,095 | +8.6% | 0.00% | 0.0% |
| Q3 2022 | $291,000 | -3.0% | 12,062 | +10.3% | 0.00% | 0.0% |
| Q2 2022 | $300,000 | -31.7% | 10,940 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $439,000 | +6.0% | 11,460 | -11.5% | 0.00% | 0.0% |
| Q4 2021 | $414,000 | -6.3% | 12,942 | -13.7% | 0.00% | 0.0% |
| Q3 2021 | $442,000 | -31.0% | 14,992 | -19.0% | 0.00% | 0.0% |
| Q2 2021 | $641,000 | -77.2% | 18,508 | -78.5% | 0.00% | -83.3% |
| Q1 2021 | $2,814,000 | +49.6% | 86,208 | +65.1% | 0.01% | +50.0% |
| Q4 2020 | $1,881,000 | +119.2% | 52,231 | +138.5% | 0.00% | +100.0% |
| Q3 2020 | $858,000 | +121.7% | 21,896 | +107.5% | 0.00% | +100.0% |
| Q2 2020 | $387,000 | +21.3% | 10,550 | -23.8% | 0.00% | 0.0% |
| Q1 2020 | $319,000 | +6.7% | 13,847 | +35.3% | 0.00% | 0.0% |
| Q4 2019 | $299,000 | -93.7% | 10,232 | -94.2% | 0.00% | -92.3% |
| Q3 2019 | $4,732,000 | +1431.4% | 177,190 | +1365.2% | 0.01% | +1200.0% |
| Q2 2019 | $309,000 | +14.0% | 12,093 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $271,000 | +163.1% | 12,093 | +147.5% | 0.00% | – |
| Q4 2018 | $103,000 | +14.4% | 4,887 | 0.0% | 0.00% | – |
| Q3 2018 | $90,000 | -17.4% | 4,887 | 0.0% | 0.00% | – |
| Q2 2018 | $109,000 | -23.2% | 4,887 | -24.5% | 0.00% | – |
| Q1 2018 | $142,000 | -81.9% | 6,470 | -80.8% | 0.00% | -100.0% |
| Q4 2017 | $783,000 | -6.2% | 33,698 | -7.3% | 0.00% | -33.3% |
| Q3 2017 | $835,000 | +11.5% | 36,353 | +7.2% | 0.00% | +50.0% |
| Q2 2017 | $749,000 | -2.5% | 33,925 | +0.7% | 0.00% | -33.3% |
| Q1 2017 | $768,000 | +8.9% | 33,698 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $705,000 | -39.0% | 33,698 | -22.9% | 0.00% | -25.0% |
| Q3 2016 | $1,155,000 | +35.1% | 43,703 | +41.6% | 0.00% | +33.3% |
| Q2 2016 | $855,000 | – | 30,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |